Get Started with NeoGenomics
IHC & ISH
NeoTYPE® Cancer Profiles
With solid tumors accounting for approximately 90% of new cancer diagnoses*, expert professional staff, a robust test menu, and strong support services are critical features of a reference lab. Our program is highly flexible to allow any level of service from comprehensive consultation to global case reports to technical-only FISH and stain-only immunohistochemistry.
*Cancer Facts & Figures 2016 page, estimated new cases. American Cancer Society website. Click here Accessed 7-3-16.